Societies Aid In Large-Scale Effort To Support Russian Science

The International Science Foundation for the Former Soviet Union (ISF), with the help of discipline-specific panels composed of representatives of United States scientific organizations and more than 200 American and European scientists, is conducting what participants are calling an unprecedented peer-review process. The effort is scheduled to culminate this month with the funding of about 900 research proposals from scientists in

Written byTracey Webb
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The International Science Foundation for the Former Soviet Union (ISF), with the help of discipline-specific panels composed of representatives of United States scientific organizations and more than 200 American and European scientists, is conducting what participants are calling an unprecedented peer-review process. The effort is scheduled to culminate this month with the funding of about 900 research proposals from scientists in Russia and other Baltic states.

The grants will total $45 million to $50 million and will fund 10 percent to 20 percent of the proposals under consideration, according to Chris Williams, an executive assistant at ISF who is involved in the grant-review process. Williams says that, in all, 11,000 proposals were submitted to ISF; of these, he notes, 9,000 passed a formal screening of minimum requirements.

"The criteria [were] rather strict, but even though the scientists in the former Soviet Union are confined by a crumbling technical and equipment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies